Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein
- PMID: 20429629
Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein
Abstract
Deleted in breast cancer 1 (DBC1, KIAA1967, p30 DBC) is a novel protein that has been suggested to be a critical regulator of tumorigenesis. DBC1 modulates the activities of various proteins, including SIRT1, ERalpha, RARalpha, and AR. The functions of DBC1 with target molecules have been investigated, but little is known of its molecular characteristics. We found that DBC1 is homo-oligomerized and exhibits a dynamic expression pattern during cell cycle. In addition, DBC1 expression is higher in lung cancer cells than in normal lung fibroblasts and the protein recognized by anti-DBC1 antibodies in normal cells differs from that in lung and breast cancer cells. Further examination of the oligomerization and the dynamic expression of DBC1 during the cell cycle will help us to understand the mechanisms of DBC1 function. Moreover, the elucidation about differential expression of DBC1 between normal cells and cancer cells will aid the development of DBC1 as a diagnostic marker for cancers.
Similar articles
-
Repression of estrogen receptor beta function by putative tumor suppressor DBC1.Biochem Biophys Res Commun. 2010 Feb 12;392(3):357-62. doi: 10.1016/j.bbrc.2010.01.025. Epub 2010 Jan 13. Biochem Biophys Res Commun. 2010. PMID: 20074560
-
A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo.Sci Rep. 2019 Oct 7;9(1):14381. doi: 10.1038/s41598-019-50789-7. Sci Rep. 2019. PMID: 31591441 Free PMC article.
-
Molecular characterization, alternative splicing and expression analysis of bovine DBC1.Gene. 2013 Sep 25;527(2):689-93. doi: 10.1016/j.gene.2013.05.065. Epub 2013 Jul 9. Gene. 2013. PMID: 23845782
-
Advances on the role of the deleted in breast cancer (DBC1) in cancer and autoimmune diseases.J Leukoc Biol. 2021 Feb;109(2):449-454. doi: 10.1002/JLB.6MR0320-086R. Epub 2020 Apr 26. J Leukoc Biol. 2021. PMID: 32337788 Review.
-
p30 DBC is a potential regulator of tumorigenesis.Cell Cycle. 2009 Sep 15;8(18):2932-5. doi: 10.4161/cc.8.18.9473. Epub 2009 Sep 8. Cell Cycle. 2009. PMID: 19657230 Free PMC article. Review.
Cited by
-
DBC1 is over-expressed and associated with poor prognosis in colorectal cancer.Int J Clin Oncol. 2014 Feb;19(1):106-12. doi: 10.1007/s10147-012-0506-5. Epub 2013 Jan 9. Int J Clin Oncol. 2014. PMID: 23299276
-
Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients.Onco Targets Ther. 2019 Feb 22;12:1563-1574. doi: 10.2147/OTT.S189618. eCollection 2019. Onco Targets Ther. 2019. PMID: 30863120 Free PMC article.
-
Expression of SIRT1 and DBC1 in Developing and Adult Retinas.Stem Cells Int. 2012;2012:908183. doi: 10.1155/2012/908183. Epub 2012 Aug 30. Stem Cells Int. 2012. PMID: 22969813 Free PMC article.
-
CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells.Tumour Biol. 2014 Nov;35(11):10919-29. doi: 10.1007/s13277-014-2370-6. Epub 2014 Aug 2. Tumour Biol. 2014. PMID: 25085583
-
CCAR2 controls mitotic progression through spatiotemporal regulation of Aurora B.Cell Death Dis. 2022 Jun 7;13(6):534. doi: 10.1038/s41419-022-04990-8. Cell Death Dis. 2022. PMID: 35672287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials